Physician profile
Cecile A Walker
NPI 1275572216
$1,940.38
in general payments reported to CMS, 2019-2025
20 companies · $35.39 in 2025
The $35.39 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $43.05 · 2021: $227 · 2022: $728 · 2023: $447 · 2024: $258 · 2025: $35.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $444.29 | 2022-2024 | Nexplanon |
| Abbvie INC. | $246.37 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $235.62 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $199.37 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $177.36 | 2020-2023 | Summit Doppler |
| Shield Therapeutics INC | $132.17 | 2022-2025 | Accrufer |
| Medical Device Business Services, INC. | $95.83 | 2019 | |
| Pfizer INC. | $80.45 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.13 | 2020-2023 | |
| Scynexis, INC. | $49.45 | 2022 | |
| Caldera Medical, INC | $47.53 | 2022 | |
| Astellas Pharma US INC | $33.08 | 2024 | Veozah |
| Pacira Pharmaceuticals Incorporated | $18.79 | 2021 | |
| Vertical Pharmaceuticals, LLC | $17.96 | 2019 | |
| Agile Therapeutics, INC. | $17.34 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.39 | 2024 | Wegovy |
| Hologic Sales and Service, LLC | $15.99 | 2021 | |
| Therapeuticsmd, INC. | $14.71 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.39 | 2019 | |
| Merck Sharp & Dohme LLC | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecile Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.